Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx
V. Ribrag et al., Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx, LEUKEMIA, 15(7), 2001, pp. 1123-1126
Nasal NWT cell is a rare form of usually localized non-Hodgkin's lymphoma (
NHL) which generally carries a poor prognosis when treated with conventiona
l NHL chemotherapy protocols. We reviewed 20 consecutive localized stage I/
II nasal NK/T cell lymphomas treated at our institution over a 29 year peri
od. Median age was 44 (range 23-71). Front-line therapy was generally radio
therapy alone (35-70 Gy) before 1980 and combination chemotherapy after 198
0. Six patients were treated with first-line radiotherapy and they achieved
complete remission (CR). Two subsequently received combination chemotherap
y. Five of those patients remained in complete remission, after 97+ to 277 months. Twelve patients were treated with first-line chemotherapy includin
g CHOP or CHOP-like regimen in seven cases, and COP in five cases. Only thr
ee of them achieved CR, five had partial response and four had progressive
disease. Five of the seven patients treated with CHOP did not achieve compl
ete remission. The nine patients who failed to achieve CR with chemotherapy
subsequently received salvage radiotherapy but only two of them obtained C
R. Finally, two patients were treated with alternated chemotherapy and radi
otherapy and achieved CR, which persisted after 14+ and 26+ months. Median
survival was not reached in patients who received front-line radiotherapy,
and was 35 months in patients who received front-line chemotherapy. These f
indings confirm that chemotherapy gives a low complete remission rate in lo
calized nasal NK/T cell lymphoma. By contrast, first-line radiotherapy seem
s to give favorable results, whereas its results are poorer when administer
ed after resistance to chemotherapy. Whether the use of chemotherapy after
radiotherapy, or alternated chemotherapy-radiotherapy regimens give better
clinical results than radiotherapy alone will have to be evaluated prospect
ively in this type of NHL.